Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
India faces a major health challenge with diabetes cases projected to reach 124.9 million by 2045. A team at NIT Rourkela has ...
Drinking a tablespoon of apple cider vinegar diluted in a glass of water before meals can help improve insulin sensitivity ...
Researchers have found that people with diabetes can achieve the same positive results using advanced insulin technology when trained by their primary care providers (PCPs) or through telehealth as ...
A team of scientists at the University of Michigan hopes to replicate the results in cells from diabetic patients and open ...
There are calls for the government to follow through on a parliamentary inquiry's recommendation for expanded access to ...
StockStory.org on MSN1h
Tandem Diabetes (TNDM) Q4 Earnings: What To ExpectDiabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s ...
GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results